PRECIGEN INC
PRECIGEN INC
Share · US74017N1054 · PGEN · A2PZG1 (XNAS)
Overview Financial Indicators
1,51 USD
10,78 % 0,15 USD
NASDAQ (XNAS) · Current prices and charts at MoneyPeak
06.06.2025 17:56

Current Prices from PRECIGEN INC

ExchangeTickerCurrencyLast TradePriceDaily Change
XNAS: NASDAQ
NASDAQ
PGEN
USD
06.06.2025 17:56
1,51 USD
1,33 USD
+13,16 %

Performance

Day Week Month 3 Months 6 Months 1 Year 5 Years
10,78 % 13,58 % -0,99 % -22,02 % 94,70 % -14,00 % -53,12 %

Company Profile for PRECIGEN INC Share

Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorporates advanced DNA construction technologies and computational models to design and assemble genetic components into complex gene expression programs; mbIL15, a gene that enhances functional characteristics of immune cells; Sleeping Beauty, a non-viral transposon/transposase system; AttSite recombinases, which breaks and rejoins DNA at specific sequences; AdenoVerse technology platform, a library of engineered adenovector serotypes; and L. lactis is a food-grade bacterium. Additionally, it provides RheoSwitch, an inducible gene switch system that provides quantitative dose-proportionate regulation of the amount and timing of target protein expression; kill switches to selectively eliminate cell therapies in vivo; tissue-specific promoters; UltraCAR-T platform for the treatment of cancer; AdenoVerse Immunotherapy, a library of proprietary adenovectors for the gene delivery; and ActoBiotics platform, genetically modified bacteria that deliver proteins and peptides at mucosal sites. Precigen, Inc. has collaboration and license agreements with Alaunos Therapeutics, Inc.; Ares Trading S.A.; Oragenics, Inc.; Castle Creek Biosciences, Inc.; Intrexon Energy Partners, LLC; and Intrexon Energy Partners II, LLC. The company was formerly known as Intrexon Corporation and changed its name to Precigen, Inc. in January 2020. Precigen, Inc. was founded in 1998 and is based in Germantown, Maryland.

Invested Funds

The following funds have invested in: PRECIGEN INC invested:

Fund
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Vol. in million
42,33
Percentage (%)
0,10 %

Company Data

Name PRECIGEN INC
Company Precigen, Inc.
Symbol PGEN
Website https://www.precigen.com
Primary Exchange XNAS NASDAQ
WKN A2PZG1
ISIN US74017N1054
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Dr. Helen Sabzevari MPH, Ph.D.
Market Capitalization 409 Mio
Country United States of America
Currency USD
Employees 0,1 T
Address 20374 Seneca Meadows Parkway, 20876 Germantown
IPO Date 2013-08-08

ID Changes

Date From To
03.02.2020 XON PGEN

Ticker Symbols

Name Symbol
Frankfurt I5X.F
NASDAQ PGEN

More Shares

Investors who PRECIGEN INC hold also have the following shares in their portfolio:
AMGEN INC
AMGEN INC Share
ANSYS INC
ANSYS INC Share
AUTODESK INC
AUTODESK INC Share
BANK OF AMERICA 2037
BANK OF AMERICA 2037 Bond
CISCO SYSTEMS INC
CISCO SYSTEMS INC Share
COSTCO WHOLESALE CORP
COSTCO WHOLESALE CORP Share
HSBC S 20/28 FLR
HSBC S 20/28 FLR Bond
INCYTE CORP
INCYTE CORP Share
INTEL CORP
INTEL CORP Share
MICROSOFT CORP
MICROSOFT CORP Share
MONDELEZ INTERNATIONAL INC - CLASS A
MONDELEZ INTERNATIONAL INC - CLASS A Share
PAYCO SOFTWARE INC
PAYCO SOFTWARE INC Share
PICTET-EUR COR.BDS P
PICTET-EUR COR.BDS P Fund
WALGREENS BOOTS ALLIANCE INC
WALGREENS BOOTS ALLIANCE INC Share
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025